FDA PMA
FDA Class 3
Approved
🇺🇸 United States
Separator For Therapeutic Purposes, Membrane Automated Blood Cell/Plasma
PMA: P830063
·
Supplement: S016
·
Decision May 23, 2020
Classifications
1
FEI Numbers
5
Registration Numbers
5
Basic Information
- Device Name
- Separator For Therapeutic Purposes, Membrane Automated Blood Cell/Plasma
- Trade Name
- PRISMAFLEX TPE 2000 Set
- PMA Number
- P830063
- Supplement Number
- S016
- Device Class
- FDA Class 3
- Product Code
- MDP
- Generic Name
- Separator for therapeutic purposes, membrane automated blood cell/plasma
- Medical Specialty
- Unknown
- Advisory Committee
- Gastroenterology, Urology
- Decision
- Approved
- Decision Code
- APPR
- Decision Date
- May 23, 2020
- Date Received
- March 5, 2020
- Supplement Type
- Real-Time Process
- Supplement Reason
- Change Design/Components/Specifications/Material
- Expedited Review
- N
Advisory Committee Statement
Approval for a minor change to the raw material used for the header cap component, which is part of the plasmafilter subassembly of the PRISMAFLEX TPE2000 Set.
Classifications
This FDA Pre-Market Approval entry is associated with 1 FDA classification via its product code.
| Product Code | Device Name | Device Class | Medical Specialty |
|---|---|---|---|
| MDP | Separator For Therapeutic Purposes, Membrane Automated Blood Cell/Plasma | FDA class 3 | Unknown |